This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Sodium Chloride Injection USP 23.4% (2016-07-05)
- Starting date:
- July 5, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-59316
Affected products
A. Sodium Chloride Injection USP 23.4%
Reason
Out of specification result for pH during stability testing.
Depth of distribution
Retailers across Canada
Affected products
A. Sodium Chloride Injection USP 23.4%
DIN, NPN, DIN-HIM
DIN 00402230
Dosage form
Solution
Strength
234 mg/mL
Lot or serial number
"4D603
4F660
4F675
4K771
4L796
5A864
5B889
5C921
5D965
5F016
"
Companies
- Recalling Firm
-
Omega Laboratories Ltd. 11177 Hamon Montreal, Quebec H3M 3E4
- Marketing Authorization Holder
-
Omega Laboratories Ltd. 11177 Hamon Montreal, Quebec H3M 3E4